This document is intended to provide a company profile and introduction for Aligos Therapeutics. Further details about the company's operations, financial performance, and strategic direction would typically be included in a complete profile.
American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have reported a joint beneficial ownership of 5.7% in Gold.com, Inc. common stock. This stake, totaling 1,644,385 shares, was held as of June 30, 2026, with the entities exercising …
Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have reported a beneficial ownership of 1,319,910 Class A Ordinary Shares in Lionheart Holdings (CUB), which represents a 6.1% stake in the company. Both entities hold shared voting and dispositive power over these shares, …
Wells Fargo & Company has filed its Form 13F Holdings Report, disclosing $617.4 billion in equity holdings across 18,984 positions. The report includes six other affiliated managers, such as Wells Fargo Clearing Services, LLC, and was signed by Patricia Arce. This filing provides insights …
This article first appeared on GuruFocus. Nvidia (NASDAQ:NVDA) is moving to solve one of the AI boom's biggest emerging constraints: financing. Goldman Sachs (NYSE:GS) is reportedly sounding out insurers, banks and asset managers for Nvidia's plan to mobilize more than $500 billion for AI …
Wells Fargo announced it will permanently close its downtown Morganton branch at 101 W. Union St. in November. All operations will relocate to its other Morganton location at 801 S. Sterling St. within Morganton Plaza. The company cites a mission to modernize its branches, …
Seabridge Gold reported a significant increase in Q2 2026 net income to $117.5 million, largely due to gains from spinning out the Courageous Lake project. The company is actively advancing its KSM project with major field programs and infrastructure development, supported by a newly …
Golar LNG Limited (GLNG) reported strong second-quarter 2026 results, exceeding both earnings and revenue estimates and showing significant year-over-year improvement. The company posted earnings of 68 cents per share and revenues of $130.5 million, with adjusted EBITDA increasing by 159%. GLNG also declared a …
Wells Fargo & Company has lowered its price target for Cabaletta Bio (NASDAQ:CABA) from $4.00 to $3.00, while maintaining an "equal weight" rating, suggesting a potential upside of 12.57%. Analyst opinions are varied, with MarketBeat reporting a "Moderate Buy" consensus and a $15.33 average …
Golar LNG's chief executive declined to disclose details about their next floating liquefaction contract, while emphasizing the impact of cost inflation on recent orders. The article highlights that Golar LNG is being secretive regarding its clients.
Ameriprise Financial, through its subsidiaries Columbia Management Investment Advisers and Columbia Seligman Technology and Information Fund, has disclosed a beneficial ownership of 9.2% of GoDaddy Inc.'s Class A common stock as of June 30, 2026. This stake amounts to 12,207,431 shares, with the Columbia …
Algorhythm Holdings Inc has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters and republished on TradingView News, provides an overview of the company's financial performance during this period. Readers can access the full report and …
Algorhythm Holdings (NASDAQ: RIME) reported Q2 2026 EPS of $(0.25), significantly beating the $(0.36) analyst consensus. Revenue reached $3.005 million, exceeding estimates by 0.17% and representing a 161% year-over-year increase, driven by strategic expansions in North America and India. Despite top-line growth, the company's …
T. Rowe Price Investment Management, Inc. has filed an updated ownership report for Goosehead Insurance Inc. (GSHD), indicating beneficial ownership of 602,345 shares, which represents 2.5% of the common stock. The firm holds sole voting power over 600,854 shares and sole dispositive power over …
Wells Fargo & Company has reduced its price target for Sunrun (NASDAQ:RUN) from $22.00 to $17.00, while maintaining an "overweight" rating. This new target suggests a potential upside of approximately 63.54% from its current trading price of $10.39. Despite mixed analyst sentiment, Sunrun recently …
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.